Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06358001
What this trial is testing

EchoTip AcuCore Post-Market Clinical Study

Who this might be right for
AdenocarcinomaNeuroendocrine TumorsHepatocellular Carcinoma+5 more
Cook Research Incorporated 183
Not applicableUnknownNCT05714475
What this trial is testing

Pancreas Resection for Colorectal Metastasis: Retrospective Study

Who this might be right for
Pancreas MetastasesColorectal Cancer
Ospedale Generale Di Zona Moriggia-Pelascini 15
Testing effectiveness (Phase 2)Looking for participantsNCT06427239
What this trial is testing

Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Fudan University 130
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)WithdrawnNCT04037241
What this trial is testing

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Who this might be right for
Malignant Tumor of Pancreas Metastatic to Liver
Sorrento Therapeutics, Inc.
Not applicableStudy completedNCT05226572
What this trial is testing

Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results

Who this might be right for
Pancreatic AdenocarcinomaPancreas CancerPancreas Metastases
University of Bologna 462
Testing effectiveness (Phase 2)Study completedNCT01360593
What this trial is testing

Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
David A. Clump, MD, PhD 35
Testing effectiveness (Phase 2)Looking for participantsNCT06048484
What this trial is testing

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Gulam Manji 60
Testing effectiveness (Phase 2)Study completedNCT00201838
What this trial is testing

Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 38
Early research (Phase 1)Study completedNCT03307148
What this trial is testing

Stromal TARgeting for PAncreatic Cancer (STAR_PAC)

Who this might be right for
Pancreatic Adenocarcinoma
Barts & The London NHS Trust 29
Not applicableStudy completedNCT01315548
What this trial is testing

Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic Masses

Who this might be right for
Adenocarcinoma PancreasChronic Pancreatitis
University of Medicine and Pharmacy Craiova 210
Testing effectiveness (Phase 2)Study completedNCT01978184
What this trial is testing

Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine

Who this might be right for
Pancreatic Cancer
Nathan Bahary, MD 104
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Large-scale testing (Phase 3)Ended earlyNCT01956812
What this trial is testing

Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic Cancer
Gilead Sciences 334
Not applicableUnknownNCT01522573
What this trial is testing

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

Who this might be right for
CholangiocarcinomaPancreatic CancerBile Duct Cancer+11 more
Weill Medical College of Cornell University 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07478523
What this trial is testing

FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers

Who this might be right for
CholangiocarcinomaPancreatic Adenocarcinoma
University Hospital, Bordeaux 120
Large-scale testing (Phase 3)UnknownNCT01065870
What this trial is testing

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

Who this might be right for
Pancreatic Cancer Stage IIPancreatic Cancer Stage III
Columbia University 64
Not applicableStudy completedNCT03513705
What this trial is testing

Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)

Who this might be right for
Carcinoma, Pancreatic Ductal
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 4,000
Testing effectiveness (Phase 2)UnknownNCT04718701
What this trial is testing

Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmMetastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 53
Next Page